Recalls That Should Be on Your Radar—Week of September 1, 2019

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

American Beef Packers, Inc., Issues Recall for Products Unfit for Consumption

American Beef Packers, Inc., a Chino, Calif. establishment, is recalling approximately 24,428 pounds of raw beef products that are deemed unfit for human consumption, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.

FSIS inspection personnel retained the carcass and collected a sample for further analysis. Prior to test results being received, the carcass was erroneously released and further processed into raw intact and non-intact beef products, which were distributed in commerce.

The raw beef items were produced and packaged on Aug. 21, 2019. The products subject to recall bear establishment number “EST. 34741” inside the USDA mark of inspection. These items were shipped to federal establishments in California and Oregon.

The firm notified FSIS on Aug. 30, 2019 that a carcass that was pending laboratory results had been erroneously released and further processed into raw intact and non-intact beef products.

There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider.

Read the full recall statement.

BCI Foods Inc., Issues Recall for Meat and Poultry Soup Products Without Benefit of Import Inspection

BCI Foods, Inc., a Quebec, Canada firm and importer of record, is recalling approximately 3,304 pounds of meat and poultry soup products that were not presented for import re-inspection, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.

The meat and poultry soup items were imported on July 17, 2019. The products subject to recall do not bear the USDA mark of inspection, but bear Canada’s establishment number “142” within the Canadian mark of inspection. These items were shipped to Aldi stores in New York and Pennsylvania.

The problem was discovered during routine FSIS monitoring activities of imported products.

There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a health care provider.

Read the full recall statement.

Dog Goods USA LLC Expands Recall of Pig Ear Dog Treats Linked to Salmonella Risk

Dog Goods is voluntarily expanding this recall to include all 30-packs of "Berkley & Jensen" brand pig ears sold at BJ's Wholesale Club stores. Dog Goods purchased these pig ears from a single supplier in Brazil from September 2018 through August 2019.

The U.S. Food and Drug Administration ("FDA"), together with the Centers for Disease Control and Prevention ("CDC") and State partners, is investigating a link between pig ear pet treats and human cases of salmonellosis. This recall is being expanded after Rhode Island Department of Health testing found Salmonella in "Berkley & Jensen" brand pig ear pet treats.

Dog Goods USA LLC ("Dog Goods"), a distributor of Tobyhanna, PA has been contacted by the FDA and, based on the best information currently available, is conducting a voluntary recall of the following products (the "Products"): non-irradiated bulk and packaged pig ears branded Chef Toby Pig Ears with the lot codes indicated below, which Dog Goods bought from a single supplier in Brazil from September 2018 through August 2019 and distributed nationwide in retail stores.

Read the full recall statement.

Pacifico National, Inc. dba AmEx Pharmacy Issues Recall for All Lots of Bevacizumab

AmEx Pharmacy today announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable that are within expiry to the healthcare provider level. These lots are being recalled out of an abundance of caution following an FDA inspection.

While all products associated with this voluntary recall passed compendial testing per USP 71 and USP 85, administration of a non-sterile drug product intended to be sterile may present the risk of infection.

The product involved in this recall is used for Wet Age-related Macular Degeneration and Diabetic Retinopathy. It is individually wrapped and labeled in a Tyvek pouch which is then placed in a labeled amber bag to protect from light. All Lots of Bevacizumab 1.25mg/0.05m 31G Injectable and Bevacizumab 2.5mg/0.1ml Normject TB Injectable are subject to this voluntary recall. The product can be identified by referencing the Lot number which is prominently displayed on the amber bag and Tyvek pouch of the product. The specific Lots were distributed nationwide to ophthalmologist clinics in the following states: AR, AZ, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, WA, WI, WV, and PR.

Read the full recall statement.